The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Bid 11.00 now, the board have nothing positive to stay apart from empty promises.
If they are so bullish on the company's prospects why are they not digging into their pockets to buy stock. They pay themselves enough!
Disgraceful
With Harl the subject is always the case!
So JW saved Christmas for the Isles of Scilly!
All they need now is the Santa outfits.
There are a great deal of frustration among investors, which is totally understandable with lack of transparency, over promising and under delivery by the board.
Just shambolic
We should be expecting FInance News in Q4 23
So we should see an announcement before News years eve.
That's if the board can fulfil their promise.
I think the recent falls has a great deal to do with lack of funding news, only 6 or so weeks until the year is out. A few investors and market are getting a little nervous on this stumbling block. As it has been dragging on for the whole calendar year.
Is the appeal hearing still taking place on the 15th of November??
When are we expecting the judicial review? Wasn't it supposed to be early August??
Why did John wood say funding will finalised in the early part of the second quarter? A pure lie.
Does he not know the basics of having a public listed/quoted company, always under promise and over deliver. NOT the other way round!
I'm sure he used the company credit card when he had his scallops/oysters during the Judicial review hearing.
What did he toast Friday results in the evening with...caviar and champagne perhaps!
Wow that's a big trade..! A big buy
Someone has done a big buy, why doesn't it show up
Why doesn't Budd and BOD buy some shares as a vote of confidence! Unless they are in a close end period.
They should really, considering their annual salary.
The sales team and CEO need to pick up the phone and start dialling!
Closed at 42.60. it can't go up everyday. Strong support especially with all the selling and profit taking today.
I expect this to be above 50p by the 30th of March
This isn't moving solely on NICE recommendation.
FDA approval is mostly likely reason. The US is a huge market in comparison to the UK.
The board will have sense not to announce a raise before NICE/FDA news. The share price will reach around 50p+ towards the end of March on the anticipation of nice recommendation/FDA news.
A raise will be announced straight after, perhaps on the day of or not soon after.
FDA news will have significant upside on the SP, much more so then NICE. There will definitely be more interest in the stock in the month ahead
All of course, My view.
Exciting two weeks ahead.
Large sell orders being filled above the bid. Someone wants these shares.
If MT-RNR1 receives FDA approval this is easily worth 50p share. Healthcare in the US is very lucrative as we know.
What time was the trade and how many shares was the £120k trade?
What time was this trade? How many shares?
You are definitely right about daylight robbery, it effectively happened in a day.. Or shall I say a late Friday evening.. Worst possible day... I bet Mr king was drinking champagne with his director buddies in the office. Ace of spades ♠ perhaps...